Why the RBS share price rose 12% in September

G A Chester discusses the strong rise of the Royal Bank of Scotland share price last month, and gives his view on the company’s prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Royal Bank of Scotland (LSE: RBS) was the top performer of the five FTSE 100 banks in September. A 12% rise in its share price smashed the index’s gain of 3%.

In this article, I’ll discuss why its shares soared, and give my view on its current valuation and prospects.

Volatile

To begin with, it’s worth noting that RBS’s September performance followed a poor showing in August. Its shares slumped 15% that month, compared with a 5% drop for the FTSE 100, and it was the worst performer among the banks.

As August and September have shown, RBS tends to be more sensitive than its peers to changes in sentiment in the wider market. However, having acknowledged the share price is prone to volatility, let’s turn to the more concrete matter of company news.

PPI crescendo

The catalyst for RBS’s poor performance in August was its half-year results at the start of the month in which it revealed it’s “very unlikely” to achieve its 2020 financial targets “given current market conditions, continued economic and political uncertainty and the contraction of the yield curve.”

On the face of it, news in early September continued to be negative. RBS reported that the volume of PPI claims ahead of the 29 August deadline had been “significantly higher than expected,” and that it would be making an additional provision of between £600m and £900m.

Other banks made similar statements, but the market shrugged off the news across the sector. Maybe it was simply the end of the uncertainty of the long-running saga around PPI that kept share prices ticking up, or maybe market participants felt that many of the claims in the huge August spike would prove spurious, and that the banks had (for once) over-provisioned.

Analysts and Alison

The market also shrugged off several somewhat negative analyst releases on RBS over the first half of the month. The most severe came from Deutsche on 6 September. It downgraded the stock to ‘hold’ from ‘buy’, and slashed its price target to 215p from 290p.

RBS’s shares continued to march upwards, and on 20 September reached a month high of 213.5p (15% up from the end of August). This peak came on the day the company named its new chief executive as Alison Rose, almost five months after incumbent Ross McEwan announced his intention to depart. So, this was another outstanding uncertainty put to bed.

The share price eased back a little in the latter days of September, but still ended the month with the aforementioned healthy 12% gain at 207.6p.

Cyclical risk

It’s looking like October’s going to be another volatile month, ahead of the Brexit deadline, with the FTSE 100 plunging 3.2% yesterday — its biggest drop since before the Brexit vote — and RBS’s shares falling back below 200p.

However, I’m less concerned about sentiment and volatility than the risk that, whatever the Brexit outcome, we’re a lot nearer today than at any time in the last 10 years to the next cyclical downturn in the economy.

Personally, I don’t quite see a big enough margin of safety in RBS’s current share price to protect me against earnings and dividend forecasts evaporating in a recession scenario. As such, I’m content to avoid the stock at this stage.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »